ProPhase Labs esophageal cancer early detection test (BE-smart) featured in peer-reviewed article in the International Journal of Molecular Science (ProPhase Press Release)
"ProPhase Labs...announced that its flagship diagnostic test, which is undergoing clinical validation as a laboratory developed test (LDT) for esophageal cancer screening, was featured in International Journal of Molecular Science (MDPI Open-Access Publishing), volume 24, no. 4 edition. The article highlights the current clinical limitations and future molecular innovations of Barrett’s esophagus-related cancer. The authors note that progress has been made regarding genomic, transcriptomic, and proteomic approaches for molecular diagnostics of Barrett’s-related esophageal cancer as some of these research innovations and findings could be translated into full clinical adoption."